These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6172965)

  • 41. Interactions of antitumor triazoloacridinones with DNA.
    Koba M; Konopa J
    Acta Biochim Pol; 2007; 54(2):297-306. PubMed ID: 17446935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Caffeine dissociates complexes between DNA and intercalating dyes: application for bleaching fluorochrome-stained cells for their subsequent restaining and analysis by laser scanning cytometry.
    Bedner E; Du L; Traganos F; Darzynkiewicz Z
    Cytometry; 2001 Jan; 43(1):38-45. PubMed ID: 11122483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intercalating drugs and low temperatures inhibit synthesis and processing of ribosomal RNA in isolated human mitochondria.
    Gaines G; Attardi G
    J Mol Biol; 1984 Feb; 172(4):451-66. PubMed ID: 6694216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.
    Sinha R; Islam MM; Bhadra K; Kumar GS; Banerjee A; Maiti M
    Bioorg Med Chem; 2006 Feb; 14(3):800-14. PubMed ID: 16202606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction between the novel intercalator diethidium cation and B-form DNA: a theoretical study.
    Monaco RR; Polkosnik W
    J Biomol Struct Dyn; 1996 Aug; 14(1):13-9. PubMed ID: 8877557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent development in [1,4]benzodiazepines as potent anticancer agents: a review.
    Gill RK; Kaushik SO; Chugh J; Bansal S; Shah A; Bariwal J
    Mini Rev Med Chem; 2014; 14(3):229-56. PubMed ID: 25311001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel isoxazole polycyclic aromatic hydrocarbons as DNA-intercalating agents.
    Rescifina A; Varrica MG; Carnovale C; Romeo G; Chiacchio U
    Eur J Med Chem; 2012 May; 51():163-73. PubMed ID: 22405647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 7-Substituted actinomycin D (NSC-3053) analogs as fluorescent DNA-binding and experimental antitumor agents.
    Modest EJ; Sengupta SK
    Cancer Chemother Rep; 1974; 58(1):35-48. PubMed ID: 4812836
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of hepatitis B virus specific DNA polymerase by intercalating agents.
    Hess G; Arnold W; Möller B; Gahl GM; Meyer zum Büschenfelde KH
    Med Microbiol Immunol; 1980 Feb; 168(1):25-34. PubMed ID: 7382912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isoquino[4,5-bc]acridines: design, synthesis and evaluation of DNA binding, anti-tumor and DNA photo-damaging ability.
    Yang P; Yang Q; Qian X; Tong L; Li X
    J Photochem Photobiol B; 2006 Sep; 84(3):221-6. PubMed ID: 16714120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cytochemical methodology applied to the study of staining mechanisms and fluorescence of nucleic acids].
    Espelosín RH; Armas-Portela R; Cañete M; Juarranz A; Stockert JC
    Rev Esp Oncol; 1982; 29(3):401-12. PubMed ID: 6084269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular AND-logic for dually controlled activation of a DNA-binding spiropyran.
    Hammarson M; Andersson J; Li S; Lincoln P; Andréasson J
    Chem Commun (Camb); 2010 Oct; 46(38):7130-2. PubMed ID: 20820507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of DNA dynamics and drug-DNA interaction by steady state fluorescence anisotropy.
    Genest D; Mirau PA; Kearns DR
    Nucleic Acids Res; 1985 Apr; 13(7):2603-15. PubMed ID: 4000964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Some new aspects of actinomycin D-nucleic acid binding.
    Takusagawa F; Berman HM
    Cold Spring Harb Symp Quant Biol; 1983; 47 Pt 1():315-21. PubMed ID: 6574848
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular modelling of DNA-antitumour drug intercalation interactions: correlation of structural and energetic features with biological properties for a series of phenylquinoline-8-carboxamide compounds.
    McKenna R; Beveridge AJ; Jenkins TC; Neidle S; Denny WA
    Mol Pharmacol; 1989 May; 35(5):720-8. PubMed ID: 2725476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of ethidium bromide causes dissociation of the nucleosome core particle.
    McMurray CT; van Holde KE
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8472-6. PubMed ID: 3464964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding to DNA and cytotoxic evaluation of ascididemin, the major alkaloid from the Mediterranean ascidian Cystodytes dellechiajei.
    Bonnard I; Bontemps N; Lahmy S; Banaigs B; Combaut G; Francisco C; Colson P; Houssier C; Waring MJ; Bailly C
    Anticancer Drug Des; 1995 Jun; 10(4):333-46. PubMed ID: 7786398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of chromatin structural transitions by means of intercalator dyes.
    Krajewski WA; Lagarkova MA; Sharova NP; Stolyarov SD; Ausio J
    Dokl Biochem Biophys; 2001; 378():150-2. PubMed ID: 11712165
    [No Abstract]   [Full Text] [Related]  

  • 59. Structural and sequence-dependent aspects of drug intercalation into nucleic acids.
    Neidle S; Abraham Z
    CRC Crit Rev Biochem; 1984; 17(1):73-121. PubMed ID: 6094101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of the effects of intercalating and non-intercalating drugs on DNA structure.
    Montecucco A; Spadari S; Focher F; Pedrali-Noy G; Sala C; Palù G; Ciarrocchi G
    Biochem Pharmacol; 1988 May; 37(9):1853-4. PubMed ID: 3163926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.